Argon Denims Limited (DSE:ARGONDENIM)

Ligand Pharmaceuticals Revenue

Argon Denims had revenue of 1.32B BDT in the quarter ending March 31, 2025, a decrease of -0.89%. This brings the company's revenue in the last twelve months to 5.83B, up 6.44% year-over-year. In the fiscal year ending June 30, 2024, Argon Denims had annual revenue of 5.67B with 24.57% growth.

• Revenue (ttm): 5.83B
• Revenue Growth: +6.44%
• P/S Ratio: 0.42
• Revenue / Employee: 10.16M
• Employees: 574
• Market Cap: 2.46B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	5.67B	1.12B	24.57%
Jun 30, 2023	4.56B	-140.65M	-3.00%
Jun 30, 2022	4.70B	1.66B	54.85%
Jun 30, 2021	3.03B	-82.91M	-2.66%
Jun 30, 2020	3.12B	-333.15M	-9.66%